SUBSCRIBE
SUBSCRIBE
News   FDA

RaySearch Laboratories: First Product from Collaboration Between RaySearch and TomoTherapy Receives FDA Clearance

January 27, 2009 | 
1 min read
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) and TomoTherapy Inc. announced today that the new software solution SharePlan™ has received 510(k) clearance by the FDA and can now be market launched.
FDA Approvals Europe
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
 · 
2 min read
 · 
Jef Akst
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong